Clinical trial
Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer…
NCT00473577 · Pharmacyclics LLC., Industry · Completed
Key facts
| NCT number | NCT00473577 |
|---|---|
| Title | Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients |
| Official title | Two Phase, Open-Label, Sequential, Ascending Dose Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients |
| Lead sponsor | Pharmacyclics LLC., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hematologic Neoplasms, Neoplasms |
| Intervention type | Drug |
| Interventions | CRA-24781 |
| Enrollment | 40 |
| Start date | Aug 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | May 15, 2007 |
| Last update posted | Aug 25, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: